These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33071044)

  • 21. Single-Dilution COVID-19 Antibody Test with Qualitative and Quantitative Readouts.
    Bortz RH; Florez C; Laudermilch E; Wirchnianski AS; Lasso G; Malonis RJ; Georgiev GI; Vergnolle O; Herrera NG; Morano NC; Campbell ST; Orner EP; Mengotto A; Dieterle ME; Fels JM; Haslwanter D; Jangra RK; Celikgil A; Kimmel D; Lee JH; Mariano MC; Nakouzi A; Quiroz J; Rivera J; Szymczak WA; Tong K; Barnhill J; Forsell MNE; Ahlm C; Stein DT; Pirofski LA; Goldstein DY; Garforth SJ; Almo SC; Daily JP; Prystowsky MB; Faix JD; Fox AS; Weiss LM; Lai JR; Chandran K
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33883259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.
    Kouwaki T; Nishimura T; Wang G; Oshiumi H
    Front Immunol; 2021; 12():700926. PubMed ID: 34249006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
    Ramasamy S; Subbian S
    Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between Type I Interferon Associated Factors and COVID-19 Severity.
    Bencze D; Fekete T; Pázmándi K
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of plasma IFN signaling-related miRNAs during acute SARS-CoV-2 infection and its association with RBD-IgG antibody response.
    Wu J; Liu X; Shao J; Zhang Y; Lu R; Xue H; Xu Y; Wang L; Zhou H; Yu L; Yue M; Dong C
    Virol J; 2021 Dec; 18(1):244. PubMed ID: 34876159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneous Escape from X Chromosome Inactivation Results in Sex Differences in Type I IFN Responses at the Single Human pDC Level.
    Hagen SH; Henseling F; Hennesen J; Savel H; Delahaye S; Richert L; Ziegler SM; Altfeld M
    Cell Rep; 2020 Dec; 33(10):108485. PubMed ID: 33296655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-Lambda Intranasal Protection and Differential Sex Pathology in a Murine Model of SARS-CoV-2 Infection.
    Sohn SY; Hearing J; Mugavero J; Kirillov V; Gorbunova E; Helminiak L; Mishra S; Mackow E; Hearing P; Reich NC; Kim HK
    mBio; 2021 Dec; 12(6):e0275621. PubMed ID: 34724828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2.
    Xia H; Shi PY
    J Interferon Cytokine Res; 2020 Dec; 40(12):543-548. PubMed ID: 33337934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome.
    Caldarale F; Giacomelli M; Garrafa E; Tamassia N; Morreale A; Poli P; Timpano S; Baresi G; Zunica F; Cattalini M; Moratto D; Chiarini M; Cannizzo ES; Marchetti G; Cassatella MA; Taddio A; Tommasini A; Badolato R
    Front Immunol; 2021; 12():654587. PubMed ID: 33841438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-Related Expression of IFN-λ1
    Gilbert C; Lefeuvre C; Preisser L; Pivert A; Soleti R; Blanchard S; Delneste Y; Ducancelle A; Couez D; Jeannin P
    Front Immunol; 2021; 12():750279. PubMed ID: 34858406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection.
    Pérez-Gómez A; Vitallé J; Gasca-Capote C; Gutierrez-Valencia A; Trujillo-Rodriguez M; Serna-Gallego A; Muñoz-Muela E; Jiménez-Leon MLR; Rafii-El-Idrissi Benhnia M; Rivas-Jeremias I; Sotomayor C; Roca-Oporto C; Espinosa N; Infante-Domínguez C; Crespo-Rivas JC; Fernández-Villar A; Pérez-González A; López-Cortés LF; Poveda E; Ruiz-Mateos E;
    Cell Mol Immunol; 2021 Sep; 18(9):2128-2139. PubMed ID: 34290398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases.
    Castillo-Olivares J; Wells DA; Ferrari M; Chan ACY; Smith P; Nadesalingam A; Paloniemi M; Carnell GW; Ohlendorf L; Cantoni D; Mayora-Neto M; Palmer P; Tonks P; Temperton NJ; Peterhoff D; Neckermann P; Wagner R; Doffinger R; Kempster S; Otter AD; Semper A; Brooks T; Albecka A; James LC; Page M; Schwaeble W; Baxendale H; Heeney JL
    Front Immunol; 2021; 12():748291. PubMed ID: 34867975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
    Changrob S; Fu Y; Guthmiller JJ; Halfmann PJ; Li L; Stamper CT; Dugan HL; Accola M; Rehrauer W; Zheng NY; Huang M; Wang J; Erickson SA; Utset HA; Graves HM; Amanat F; Sather DN; Krammer F; Kawaoka Y; Wilson PC
    mBio; 2021 Dec; 12(6):e0297521. PubMed ID: 34781736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex-based clinical and immunological differences in COVID-19.
    Huang B; Cai Y; Li N; Li K; Wang Z; Li L; Wu L; Zhu M; Li J; Wang Z; Wu M; Li W; Wu W; Zhang L; Xia X; Wang S; Chen H; Wang Q
    BMC Infect Dis; 2021 Jul; 21(1):647. PubMed ID: 34225644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.
    Conti P; Younes A
    J Biol Regul Homeost Agents; 2020 March-April,; 34(2):339-343. PubMed ID: 32253888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection.
    Choe PG; Kang CK; Suh HJ; Jung J; Song KH; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Park WB; Oh MD
    Emerg Infect Dis; 2021 Jan; 27(1):327-9. PubMed ID: 33050983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ravaging SARS-CoV-2: rudimentary diagnosis and puzzling immunological responses.
    Mukherjee TK; Malik P; Maitra R; Hoidal JR
    Curr Med Res Opin; 2021 Feb; 37(2):207-217. PubMed ID: 33306409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type I and III interferon responses in SARS-CoV-2 infection.
    Kim YM; Shin EC
    Exp Mol Med; 2021 May; 53(5):750-760. PubMed ID: 33953323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.